Three-Year Outcomes After Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease Insights From the j-Cypher Registry

被引:78
|
作者
Toyofuku, Mamoru [4 ]
Kimura, Takeshi [1 ]
Morimoto, Takeshi [2 ,3 ]
Hayashi, Yasuhiko [4 ]
Ueda, Hiroaki [4 ]
Kawai, Kazuya [8 ]
Nozaki, Yoichi [7 ]
Hiramatsu, Shinichi [6 ]
Miura, Akira [5 ]
Yokoi, Yoshiaki [13 ]
Toyoshima, Shinichiro [12 ]
Nakashima, Hitoshi [11 ]
Haze, Kazuo [10 ]
Tanaka, Masaru [9 ]
Take, Shunsuke [16 ]
Saito, Shigeru [15 ]
Isshiki, Takaaki [14 ]
Mitsudo, Kazuaki [17 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto 6068507, Japan
[3] Kyoto Univ, Grad Sch Med, Clin Epidemiol Unit, Kyoto 6068507, Japan
[4] Tsuchiya Gen Hosp, Hiroshima, Japan
[5] Japanese Red Cross Soc Wakayama Med Ctr, Wakayama, Japan
[6] Ehime Prefectural Cent Hosp, Matsuyama, Ehime, Japan
[7] Hokko Mem Hosp, Sapporo, Hokkaido, Japan
[8] Chikamori Hosp, Kochi, Japan
[9] Osaka Red Cross Hosp, Osaka, Japan
[10] Osaka City Gen Hosp, Osaka, Japan
[11] Natl Hosp Org Kagoshima Med Ctr, Kagoshima, Japan
[12] Nanpuh Hosp, Kagoshima, Japan
[13] Kishiwada Tokushukai Hosp, Kishiwada, Japan
[14] Teikyo Univ Hosp, Tokyo, Japan
[15] Shonan Kamakura Gen Hosp, Kamakura, Kanagawa, Japan
[16] Saiseikai Noe Hosp, Osaka, Japan
[17] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
关键词
stents; revascularization; coronary disease; ischemia; restenosis; BYPASS-SURGERY; THROMBOSIS; STENOSIS; SURVIVAL;
D O I
10.1161/CIRCULATIONAHA.109.873349
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Long-term outcomes after stenting of an unprotected left main coronary artery (ULMCA) with drug-eluting stents have not been addressed adequately despite the growing popularity of this procedure. Methods and Results-j-Cypher is a multicenter prospective registry of consecutive patients undergoing sirolimus-eluting stent implantation in Japan. Among 12 824 patients enrolled in the j-Cypher registry, the unadjusted mortality rate at 3 years was significantly higher in patients with ULMCA stenting (n = 582) than in patients without ULMCA stenting (n = 12 242; 14.6% versus 9.2%, respectively; P < 0.0001); however, there was no significant difference between the 2 groups in the adjusted risk of death (hazard ratio 1.23, 95% confidence interval 0.95 to 1.60, P = 0.12). Among 476 patients whose ULMCA lesions were treated exclusively with a sirolimus-eluting stent, patients with ostial/shaft lesions (n = 96) compared with those with bifurcation lesions (n = 380) had a significantly lower rate of target-lesion revascularization for the ULMCA lesions (3.6% versus 17.1%, P = 0.005), with similar cardiac death rates at 3 years (9.8% versus 7.6%, P = 0.41). Among patients with bifurcation lesions, patients with stenting of both the main and side branches (n = 119) had significantly higher rates of cardiac death (12.2% versus 5.5%; P = 0.02) and target-lesion revascularization (30.9% versus 11.1%; P < 0.0001) than those with main-branch stenting alone (n = 261). Conclusions-The higher unadjusted mortality rate of patients undergoing ULMCA stenting with a sirolimus-eluting stent did not appear to be related to ULMCA treatment itself but rather to the patients' high-risk profile. Although long-term outcomes in patients with ostial/shaft ULMCA lesions were favorable, outcomes in patients with bifurcation lesions treated with stenting of both the main and side branches appeared unacceptable. (Circulation. 2009;120:1866-1874.)
引用
收藏
页码:1866 / U50
页数:16
相关论文
共 50 条
  • [21] Long-term clinical outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease
    Higami H.
    Shiomi H.
    Niki S.
    Tazaki J.
    Imai M.
    Saito N.
    Makiyama T.
    Shizuta S.
    Shioi T.
    Ono K.
    Kimura T.
    Cardiovascular Intervention and Therapeutics, 2015, 30 (3) : 189 - 197
  • [22] Risk factors for recurrence of Sirolimus-Eluting Stent restenosis: Insights from j-CYPHER registry
    Taniguchi, Takuya
    Abe, Mitsuru
    Yagi, Nobuhito
    Kokubu, Nobuaki
    Kasahara, Yoichiro
    Kataoka, Yu
    Yasuga, Yuji
    Otsuka, Yoritaka
    Kawamura, Atsushi
    Nonogi, Hiroshi
    Morimoto, Takeshi
    Mitsudo, Kazuaki
    Kimura, Takeshi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A338 - A338
  • [23] Association of Target Lesion Revascularization with Outcome in Patients with Sirolimus-Eluting Stent Implantation: Insights From j-CYPHER Registry
    Nakao, Kazuhiro
    Abe, Mitsuru
    Taniguchi, Takuya
    Yamanaka, Futoshi
    Yagi, Nobuhito
    Kokubu, Nobuaki
    Kasahara, Yoichiro
    Kataoka, Yu
    Otuka, Yoritaka
    Morimoto, Takeshi
    Kimura, Takeshi
    Mitsudo, Kazuaki
    Nonogi, Hiroshi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A49 - A49
  • [24] Antiplatelet therapy discontinuation and stent thrombosis after sirolimus-eluting stent implantation: Five-year outcome of the j-Cypher Registry
    Yano, Mariko
    Natsuaki, Masahiro
    Morimoto, Takeshi
    Nakagawa, Yoshihisa
    Kawai, Kazuya
    Miyazaki, Shunichi
    Muramatsu, Toshiya
    Shiode, Nobuo
    Namura, Masanobu
    Sone, Takahito
    Oshima, Shigeru
    Nishikawa, Hideo
    Hiasa, Yoshikazu
    Hayashi, Yasuhiko
    Nobuyoshi, Masakiyo
    Mitsudo, Kazuaki
    Kimura, Takeshi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 199 : 296 - 301
  • [25] Sirolimus-eluting stent implantation in bifurcation lesions: five-year clinical outcome of the j-Cypher registry
    Tamura, T.
    Kimura, T.
    Morimoto, T.
    Nakagawa, Y.
    Kadota, K.
    Mitsudo, K.
    EUROPEAN HEART JOURNAL, 2012, 33 : 557 - 557
  • [26] Statin reduces TLR rate as well as mortality after sirolimus-eluting stent implantation: from j-cypher registry
    Katoh, Y.
    Kimura, T. K.
    Morimoto, T. M.
    Tada, T. T.
    Furukawa, Y. F.
    Mitsudoh, K. M.
    EUROPEAN HEART JOURNAL, 2011, 32 : 233 - 234
  • [27] Sirolimus-eluting stent and unprotected left main stenosis: The multicenter e-cypher registry
    Barragan, P
    Seabra-Gomes, R
    Lotan, C
    Windecker, S
    Harb, S
    Dondi, M
    Rubino, P
    Kosinskas, E
    Urban, P
    Gershlick, A
    Wijns, W
    Commeau, P
    CIRCULATION, 2004, 110 (17) : 649 - 649
  • [28] The Incidence and Predictors of Late (Beyond 1 Year) Target Lesion Revascularization After Sirolimus-eluting Stent Implantation: From Three-year Follow-up of the j-Cypher Registry
    Nakagawa, Yoshihisa
    Mitsudo, Kazuaki
    Kimura, Takeshi
    Morimoto, Takeshi
    Muramatsu, Toshiya
    Shiode, Nobuo
    Kawai, Kazuya
    Yokoi, Yoshiaki
    Isshiki, Takaaki
    Saku, Keijiro
    Doi, Osamu
    CIRCULATION, 2009, 120 (18) : S913 - S913
  • [29] Sirolimus-eluting stent vs balloon angioplasty for the treatment of post-sirolimus-eluting stent restenosis: Insights from j-CYPHER registry
    Abe, Vitsuru
    Nonogl, Hiroshi
    Yagi, Nobuhito
    Taniguchi, Takuya
    Kokubu, Nobuaki
    Kasahara, Yoichiro
    Kataoka, Yu
    Yasuga, Yuji
    Otsuka, Yoritaka
    Kawamura, Atsushi
    Morimoto, Takeshi
    Mitsudo, Kazuaki
    Kimura, Takeshi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B89 - B89
  • [30] Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in Unprotected Left Main Coronary Artery Disease (MAIN-COMPARE Registry)
    Lee, Jong-Young
    Park, Duk-Woo
    Kim, Won-Jang
    Kim, Sung Sik
    Kim, Sung-Hwan
    Yi, Myong-Zoon
    Lee, Seung-Whan
    Kim, Young-Hak
    Lee, Cheol-Whan
    Hong, Myeong-Ki
    Park, Seong-Wook
    Park, Seung-Jung
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A76 - A76